ABEO RSI Chart
Last 7 days
5%
Last 30 days
-44.4%
Last 90 days
-37.1%
Trailing 12 Months
47.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 1.9M | 2.5M | 3.0M | 3.5M |
2022 | 1.7M | 1.6M | 1.5M | 1.4M |
2021 | 0 | 0 | 0 | 1.8M |
2020 | 0 | 0 | 10.0M | 12.2M |
2018 | 6.9M | 7.5M | 9.0M | 9.3M |
2017 | 1.0M | 843.0K | 878.0K | 837.0K |
2016 | 1.3M | 1.4M | 1.5M | 1.1M |
2015 | 358.9K | 672.8K | 986.6K | 1.3M |
2014 | 1.0M | 806.0K | 853.0K | 45.0K |
2013 | 3.8M | 3.6M | 2.9M | 2.0M |
2012 | 3.5M | 4.1M | 3.9M | 4.4M |
2011 | 2.0M | 1.9M | 1.9M | 1.8M |
2010 | 0 | 0 | 0 | 2.0M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 26, 2024 | charles faith l. | bought | 24,764 | 3.28 | 7,550 | - |
Apr 25, 2024 | o'malley brendan m. | bought | 27,864 | 3.24 | 8,600 | svp, general counsel |
Apr 25, 2024 | vazzano joseph walter | bought | 17,609 | 3.14 | 5,608 | chief financial officer |
Apr 25, 2024 | seshadri vishwas | bought | 32,000 | 3.2 | 10,000 | chief executive officer |
Mar 15, 2024 | vazzano joseph walter | sold (taxes) | -5,722 | 8.14 | -703 | chief financial officer |
Mar 04, 2024 | o'malley brendan m. | sold (taxes) | -1,429 | 7.81 | -183 | svp, general counsel |
Feb 06, 2024 | seshadri vishwas | bought | 87,800 | 4.39 | 20,000 | chief executive officer |
Jan 17, 2024 | alvino mark | sold | -36,199 | 5.11 | -7,084 | - |
Oct 16, 2023 | seshadri vishwas | sold (taxes) | -749 | 4.14 | -181 | chief executive officer |
Sep 29, 2023 | seshadri vishwas | sold (taxes) | -52,229 | 3.93 | -13,290 | chief executive officer |
Which funds bought or sold ABEO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Ikarian Capital, LLC | added | 48.1 | 3,436,300 | 6,442,300 | 0.71% |
May 16, 2024 | JANE STREET GROUP, LLC | added | 57.78 | 262,861 | 467,705 | -% |
May 15, 2024 | MORGAN STANLEY | added | 96.04 | 145,692 | 225,005 | -% |
May 15, 2024 | Western Standard LLC | added | 68.48 | 5,822,150 | 9,870,800 | 4.73% |
May 15, 2024 | Man Group plc | new | - | 535,224 | 535,224 | -% |
May 15, 2024 | Squarepoint Ops LLC | added | 45.2 | 55,170 | 105,270 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 701 | 106,925 | 117,015 | -% |
May 15, 2024 | Walleye Capital LLC | added | 41.54 | 987,367 | 1,929,330 | -% |
May 15, 2024 | BARCLAYS PLC | reduced | -66.77 | -441,000 | 409,000 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -54.95 | -89,059 | 166,816 | -% |
Unveiling Abeona Therapeutics Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Abeona Therapeutics Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Abeona Therapeutics Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2020Q4 | 2020Q3 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 | 2017Q2 | 2017Q1 | 2016Q4 |
Revenue | - | - | - | - | 3,500 | 1,784 | 68.00 | - | 1,000 | 346 | 1,673 | 3,000 | 7,000 | 482 | 1,709 | 819 | 6,275 | 215 | 219 | 217 | 186 | 256 |
Costs and Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 18,492 | 18,625 | 12,833 | 11,214 | 8,965 | 5,581 | 8,657 | 5,470 | 6,088 |
Operating Expenses | 8.5% | 14,330 | 13,209 | 11,334 | 14,054 | 12,038 | 13,004 | 9,380 | 9,008 | 20,937 | 49,652 | 17,480 | 13,248 | - | 18,625 | - | - | - | - | - | - | - |
S&GA Expenses | -100.0% | - | 5,830 | 4,156 | 5,021 | 3,997 | 5,682 | 3,890 | 3,460 | 4,224 | 4,375 | 7,397 | 4,432 | 7,631 | 4,970 | 4,627 | 2,878 | - | - | - | - | - |
R&D Expenses | -2.3% | 7,207 | 7,379 | 7,148 | 8,523 | 8,041 | 6,272 | 5,490 | 6,658 | 10,545 | 12,812 | 9,243 | 7,969 | 9,470 | 13,150 | 7,916 | - | - | - | - | - | - |
Interest Expenses | 456.9% | 607 | 109 | 105 | 103 | 101 | 178 | 157 | 200 | 201 | 53.00 | 1,388 | 1,327 | 2.00 | 3.00 | 3.00 | 3.00 | 1.00 | - | - | - | - |
Net Income | -90.3% | -31,578 | -16,591 | -11,836 | -16,654 | -9,107 | -7,121 | -6,434 | -4,097 | -22,044 | -46,683 | -15,828 | -7,237 | -17,479 | -16,419 | -12,243 | - | - | - | - | - | - |
Net Income Margin | -41.5% | -21.90* | -15.48* | -15.01* | -16.00* | -13.83* | -28.07* | -52.84* | -50.36* | -54.41* | -48.31* | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -64.6% | -15,263 | -9,272 | -5,818 | -10,332 | -11,918 | -14,017 | -6,793 | -9,013 | -13,790 | -33,505 | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 16.9% | 75.00 | 64.00 | 66.00 | 54.00 | 53.00 | 64.00 | 39.00 | 45.00 | 55.00 | 80.00 | 119 | 131 | 141 | 151 | 159 | 164 | 175 | 223 | 143 | 159 | 166 |
Current Assets | 19.7% | 67.00 | 56.00 | 57.00 | 44.00 | 43.00 | 53.00 | 25.00 | 30.00 | 39.00 | 56.00 | 68.00 | 79.00 | 89.00 | 98.00 | 105 | 109 | 119 | 132 | 50.00 | 65.00 | 72.00 |
Cash Equivalents | 23.7% | 18.00 | 14.00 | 5.00 | 6.00 | 5.00 | 14.00 | 6.00 | 6.00 | 20.00 | 33.00 | 44.00 | 27.00 | 14.00 | 13.00 | 8.00 | 15.00 | 40.00 | 129 | 48.00 | 43.00 | 26.00 |
Net PPE | 6.6% | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 6.00 | 7.00 | 7.00 | 8.00 | 12.00 | 10.00 | 10.00 | 11.00 | 11.00 | 12.00 | 13.00 | 13.00 | 13.00 | 14.00 | 14.00 | 10.00 |
Goodwill | - | - | - | - | - | - | - | - | - | - | - | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 | 32.00 |
Liabilities | 70.2% | 84.00 | 49.00 | 44.00 | 44.00 | 35.00 | 37.00 | 23.00 | 25.00 | 24.00 | 37.00 | 39.00 | 47.00 | 47.00 | 49.00 | 44.00 | 43.00 | 43.00 | 45.00 | 47.00 | 52.00 | 48.00 |
Current Liabilities | -11.4% | 12.00 | 13.00 | 8.00 | 9.00 | 7.00 | 8.00 | 13.00 | 14.00 | 12.00 | 17.00 | 26.00 | 42.00 | 41.00 | 42.00 | 39.00 | 38.00 | 37.00 | 39.00 | 20.00 | 26.00 | 21.00 |
Shareholder's Equity | -159.9% | -8.88 | 15.00 | 22.00 | 9.00 | 19.00 | 27.00 | 12.00 | 14.00 | 21.00 | 42.00 | 80.00 | 84.00 | 94.00 | 103 | 115 | 121 | 132 | 178 | 96.00 | 107 | 118 |
Retained Earnings | -4.2% | -781 | -749 | -732 | -721 | -704 | -695 | 688 | 682 | -676 | -655 | -608 | -601 | -586 | -570 | -554 | -547 | -534 | -486 | -470 | -452 | -428 |
Additional Paid-In Capital | 1.0% | 772 | 764 | 755 | 730 | 723 | 722 | 701 | 694 | 697 | 697 | 688 | 685 | 680 | 672 | 669 | 668 | 666 | 664 | 566 | 559 | 546 |
Shares Outstanding | 3.9% | 28.00 | 27.00 | 25.00 | 21.00 | 18.00 | 18.00 | 6.00 | 6.00 | 6.00 | 6.00 | 4.00 | 4.00 | 4.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 78.00 | - | - | - | 29.00 | - | - | - | 137 | - | - | - | 204 | - | - | - | 131 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -57.4% | -14,538 | -9,235 | -5,774 | -10,300 | -11,700 | -13,992 | -6,791 | -9,013 | -13,687 | -30,257 | -10,334 | -11,489 | -13,585 | -1,610 | -10,702 | -9,475 | -13,232 | -14,246 | -18,254 | -15,242 | -15,078 |
Share Based Compensation | 2.1% | 1,546 | 1,514 | 1,557 | 927 | 770 | 833 | 632 | 724 | 862 | 2,001 | 2,537 | 2,428 | 1,950 | 3,030 | 161 | 147 | 1,256 | 2,595 | 98.00 | 1,678 | 2,103 |
Cashflow From Investing | -167.8% | -7,817 | 11,529 | -18,743 | 5,211 | 2,211 | -25,290 | 1,649 | -1,398 | 1,075 | 7,999 | 26,763 | 21,924 | 9,376 | 5,782 | 4,584 | -18,209 | -75,871 | -946 | 19,228 | 18,920 | 22,774 |
Cashflow From Financing | 240.7% | 25,440 | 7,467 | 22,976 | 6,618 | -4.00 | 42,766 | 4,189 | - | - | 16,331 | 173 | 2,479 | 5,878 | 3.00 | - | - | - | 96,527 | 4,340 | 13,007 | 28.00 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues: | ||
License and other revenues | ||
Expenses: | ||
Research and development | 7,207 | 8,041 |
General and administrative | 7,123 | 3,997 |
Total expenses | 14,330 | 12,038 |
Loss from operations | (14,330) | (12,038) |
Interest income | 843 | 364 |
Interest expense | (952) | (101) |
Change in fair value of warrant and derivative liabilities | (17,301) | 2,265 |
Other income | 162 | 403 |
Net loss | $ (31,578) | $ (9,107) |
Loss per common share - basic | $ (1.16) | $ (0.54) |
Loss per common share - diluted | $ (1.16) | $ (0.54) |
Weighted average number of common shares outstanding - basic | 27,315,537 | 16,904,024 |
Weighted average number of common shares outstanding - diluted | 27,315,537 | 16,904,024 |
Other comprehensive income (loss): | ||
Change in unrealized (losses) gains related to available-for-sale debt securities | $ (118) | $ 64 |
Comprehensive loss | $ (31,696) | $ (9,043) |
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 17,558 | $ 14,473 |
Short-term investments | 44,786 | 37,753 |
Restricted cash | 338 | 338 |
Other receivables | 2,232 | 2,444 |
Prepaid expenses and other current assets | 1,811 | 729 |
Total current assets | 66,725 | 55,737 |
Property and equipment, net | 3,767 | 3,533 |
Operating lease right-of-use assets | 4,222 | 4,455 |
Other assets | 114 | 277 |
Total assets | 74,828 | 64,002 |
Current liabilities: | ||
Accounts payable | 3,362 | 1,858 |
Accrued expenses | 2,791 | 5,985 |
Current portion of operating lease liability | 1,044 | 998 |
Current portion of payable to licensor | 4,691 | 4,580 |
Other current liabilities | 1 | 1 |
Total current liabilities | 11,889 | 13,422 |
Long-term operating lease liabilities | 4,046 | 4,402 |
Long-term debt | 18,079 | |
Derivative liabilities | 1,005 | |
Warrant liabilities | 48,690 | 31,352 |
Total liabilities | 83,709 | 49,176 |
Commitments and contingencies | ||
Stockholders’ (deficit) equity: | ||
Preferred stock - $0.01 par value; authorized 2,000,000 shares; No shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | ||
Common stock - $0.01 par value; authorized 200,000,000 shares; 27,550,593 and 26,523,878 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 276 | 265 |
Additional paid-in capital | 772,129 | 764,151 |
Accumulated deficit | (781,102) | (749,524) |
Accumulated other comprehensive loss | (184) | (66) |
Total stockholders’ (deficit) equity | (8,881) | 14,826 |
Total liabilities and stockholders’ equity | $ 74,828 | $ 64,002 |